Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease-Reference-Cited by-同舟云学术

Difficulty in achieving therapeutic serum concentrations of salicylate in Kawasaki disease

Published:1984-12 Issue:6 Volume:105 Page:991-995
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Koren Gideon,MacLeod Stuart M.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference14 articles.

1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children;Kawasaki;Jpn J Allergy,1967

2. Mucocutaneous lymph node syndrome in Canada;Russel;Can Med Assoc J,1975

3. Kawasaki syndrome: An update;Melish;Hosp Pract,1982

4. Kawasaki syndrome in the United States;Bell;Am J Dis Child,1983

5. Kawasaki disease: Effect of treatment on coronary artery involvement;Kato;Pediatrics,1979

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditions;Translational and Clinical Pharmacology;2022

2. Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin;Frontiers in Pharmacology;2021-08-12

3. Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease;Pediatric Research;2018-05-02

4. Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?;Korean Circulation Journal;2013

5. Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease;The Journal of Pediatrics;2012-09